Roving Reporter Asks: How Are CGT Companies Rethinking Pricing and Reimbursement? - Top-Institutions - MDSpire

Roving Reporter Asks: How Are CGT Companies Rethinking Pricing and Reimbursement?

IBTV speaks with industry leaders at ARM’s Meeting on the Med 2026 to explore how cell and gene therapy companies are approaching pricing, reimbursement, and access as more potentially curative therapies reach patients

  • July 7, 2026

  • 2 min

Share

Top Institutions

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Pharmacology
    • Oncology
    • Cell and Gene Therapy

  • #2

    University of Chicago
    University of Chicago

    Chicago, Illinois

    Key Differentiators

    • Pharmacology
    • Health Economics

  • #3

    Duke University
    Duke University

    Durham, North Carolina

    Key Differentiators

    • Pharmacology
    • Medicine

  • #4

    University of Michigan
    University of Michigan

    Ann Arbor, Michigan

    Key Differentiators

    • Pharmacology
    • Health Management

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Pharmacology
    • Oncology

Original Source(s)

Roving Reporter Asks: How Are CGT Companies Rethinking Pricing and Reimbursement?

  • July 7, 2026

Related Content

Some cases of primary hyperparathyroidism may not be truly primary in origin

Can NSAIDs Aid DME Treatment?

Meta-analysis states that topical NSAIDs – alone or combined with anti-VEGF therapy – show significant BCVA improvements for DME

  • July 7, 2026

  • 3 min
Hospital-Based Psychosocial Case Management and Suicide Prevention in South Korea: A Randomized Clinical Trial